OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $257,942 Invested

2015

RFUMS/Chicago Medical School

Grace Stutzmann, PhD

Drug development and optimization of compounds stabilizing ryanodine calcium channels for AD

  • Funding Amount: $257,942
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Calcium Regulation
  • Status: Closed